Otsuka Pharmaceutical initiates two phase III studies of OPA-15406 ointment April 17, 2019 No Comments
Phase I/IIa trial of antibody-inducing peptide FPP-003 begins in Australia April 17, 2019 No Comments
Mallinckrodt, Washington University to jointly search for drugs targeting chronic itch April 12, 2019 No Comments